Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Blood|July 13, 2012
Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experienceAchim Rothe, Stephanie Sasse, Helen Goergen, et al.The Lancet. Haematology|October 7, 2018
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trialsBastian von Tresckow, Stefanie Kreissl, Helen Goergen, et al.Blood|February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trialsBoris Böll, Helen Goergen, Karolin Behringer, et al.British Journal of Haematology|August 16, 2021
Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study GroupDennis A Eichenauer, Ina Bühnen, Stefanie Kreissl, et al.The Lancet. Oncology|September 11, 2016
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study GroupStefanie Kreissl, Horst Mueller, Helen Goergen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study groupBoris Böll, Helen Goergen, Nils Arndt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social ReintegrationKarolin Behringer, Helen Goergen, Horst Müller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study GroupStefanie Kreissl, Horst Müller, Helen Goergen, et al.Pageof 3